Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 566

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

The Genomic Landscape of Pediatric Ewing Sarcoma

Crompton, Brian D., Stewart, Chip, Taylor-Weiner, Amaro, Alexe, Gabriela, Kurek, Kyle C., Calicchio, Monica L., Kiezun, Adam, Carter, Scott L., Shukla, Sachet A., Mehta, Swapnil S., Thorner, Aaron R., de Torres, Carmen, Lavarino, Cinzia, Suñol, Mariona, McKenna, Aaron, Sivachenko, Andrey, Cibulskis, Kristian, Lawrence, Michael S., Stojanov, Petar, Rosenberg, Mara, Ambrogio, Lauren, Auclair, Daniel, Seepo, Sara, Blumenstiel, Brendan, DeFelice, Matthew, Imaz-Rosshandler, Ivan, Schwarz-Cruz y Celis, Angela, Rivera, Miguel N., Rodriguez-Galindo, Carlos, Fleming, Mark D., Golub, Todd R., Getz, Gad, Mora, Jaume, Stegmaier, Kimberly·2014·Cancer Discovery

Abstract

Pediatric Ewing sarcoma is characterized by the expression of chimeric fusions of EWS and ETS family transcription factors, representing a paradigm for studying cancers driven by transcription factor rearrangements. In this study, we describe the somatic landscape of pediatric Ewing sarcoma. These tumors are among the most genetically normal cancers characterized to date, with only EWS–ETS rearrangements identified in the majority of tumors. STAG2 loss, however, is present in more than 15% of Ewing sarcoma tumors; occurs by point mutation, rearrangement, and likely nongenetic mechanisms; and is associated with disease dissemination. Perhaps the most striking finding is the paucity of mutations in immediately targetable signal transduction pathways, highlighting the need for new therapeutic approaches to target EWS–ETS fusions in this disease. Significance: We performed next-generation sequencing of Ewing sarcoma, a pediatric cancer involving bone, characterized by expression of EWS–ETS fusions. We found remarkably few mutations. However, we discovered that loss of STAG2 expression occurs in 15% of tumors and is associated with metastatic disease, suggesting a potential genetic vulnerability in Ewing sarcoma. Cancer Discov; 4(11); 1326–41. ©2014 AACR. This article is highlighted in the In This Issue feature, p. 1243

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-13-1037

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 566

Metadata

Authors
Crompton, B. D., Stewart, C., Taylor-Weiner, A., Alexe, G., Kurek, K. C., Calicchio, M. L., Kiezun, A., Carter, S. L., Shukla, S. A., Mehta, S. S., Thorner, A. R., de Torres, C., Lavarino, C., Suñol, M., McKenna, A., Sivachenko, A., Cibulskis, K., Lawrence, M. S., Stojanov, P., Rosenberg, M., Ambrogio, L., Auclair, D., Seepo, S., Blumenstiel, B., DeFelice, M., Imaz-Rosshandler, I., Schwarz-Cruz y Celis, A., Rivera, M. N., Rodriguez-Galindo, C., Fleming, M. D., Golub, T. R., Getz, G., Mora, J., & Stegmaier, K.
Venue
Cancer Discovery
Published
2014-11-01
Volume
4
Issue
11
Pages
1326-1341
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2124328974
Cited by
566
References
15
FWCI
26.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Genomic Landscape of Pediatric Ewing Sarcoma. https://app.cochat.ai/papers/10.1158/2159-8290.cd-13-1037
The paper
Crompton, B. D., Stewart, C., Taylor-Weiner, A., Alexe, G., Kurek, K. C., Calicchio, M. L., Kiezun, A., Carter, S. L., Shukla, S. A., Mehta, S. S., Thorner, A. R., de Torres, C., Lavarino, C., Suñol, M., McKenna, A., Sivachenko, A., Cibulskis, K., Lawrence, M. S., Stojanov, P., . . . Stegmaier, K. (2014). The Genomic Landscape of Pediatric Ewing Sarcoma. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-13-1037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.